| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Gastrointestinal cancer
First-in-Human Phase 1 Study of a B Cell– and Monocyte-Based Immunotherapeutic Vaccine against HER2-Positive Advanced Gastric Cancer
Minkyu Jung, Jii Bum Lee, Hyo Song Kim, Woo Sun Kwon, Hyun Ok Kim, Sinyoung Kim, Myunghwan Park, Wuhyun Kim, Ki-Young Choi, Taegwon Oh, Chang-Yuil Kang, Hyun Cheol Chung, Sun Young Rha
Cancer Res Treat. 2024;56(1):208-218.   Published online June 28, 2023    DOI: https://doi.org/10.4143/crt.2022.1328
                        Supplementary         Web of Science 1  Crossref 1
Breast cancer
Health-Seeking Behavior Returning to Normalcy Overcoming COVID-19 Threat in Breast Cancer
Eun-Gyeong Lee, Yireh Han, Dong-Eun Lee, Hyeong-Gon Moon, Hyoung Won Koh, Eun-Kyu Kim, So-Youn Jung
Cancer Res Treat. 2023;55(4):1222-1230.   Published online April 3, 2023    DOI: https://doi.org/10.4143/crt.2023.364
                        Supplementary      
Gastrointestinal cancer
First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017
Mee Joo Kang, Jiwon Lim, Sung-Sik Han, Hyeong Min Park, Sang-Jae Park, Young-Joo Won, Sun-Whe Kim
Cancer Res Treat. 2022;54(1):208-217.   Published online May 21, 2021    DOI: https://doi.org/10.4143/crt.2021.421
                           Web of Science 9  Crossref 9
Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer
Ah-Rong Nam, Ji-Won Kim, Ji Eun Park, Ju-Hee Bang, Mei Hua Jin, Do-Youn Oh, Yung-Jue Bang
Cancer Res Treat. 2019;51(3):886-900.   Published online October 1, 2018    DOI: https://doi.org/10.4143/crt.2018.375
                        Supplementary         Web of Science 5  Crossref 3
Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
Neehar D. Parikh, Peng Zhang, Amit G. Singal, Brian A. Derstine, Venkat Krishnamurthy, Pranab Barman, Akbar K. Waljee, Grace L. Su
Cancer Res Treat. 2018;50(2):530-537.   Published online June 1, 2017    DOI: https://doi.org/10.4143/crt.2017.156
                        Supplementary         Web of Science 22  Crossref 22
A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets
Rachna Arora, Manju Sharma, Tausif Monif, Sunil Iyer
Cancer Res Treat. 2016;48(3):1120-1129.   Published online February 12, 2016    DOI: https://doi.org/10.4143/crt.2015.436
                           Web of Science 8  Crossref 8
Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
Dongryul Oh, Sung Wook Shin, Hee Chul Park, Sung Ki Cho, Do Hoon Lim, Seung Woon Paik
Cancer Res Treat. 2015;47(2):251-258.   Published online October 27, 2014    DOI: https://doi.org/10.4143/crt.2014.011
                           Web of Science 14  Crossref 12
Therapeutic Outcome and Prognosis in Dlderly Patients with Non - Hodgkin's Lymphoma
Jee Sook Hahn, Jin Hyuk Choi, Seung Tae Lee, Yoo Hong Min, Yun Woong Ko
J Korean Cancer Assoc. 1999;31(2):320-330.
      
Clinical Trial of Human Recombinant Interleukin-2 ( IL-2
Joung Soon Jang, Jae Bum Jun, Joon Soo Hahm, Min Ho Lee, Il Young Choi, Te June Chung
J Korean Cancer Assoc. 1990;22(1):96-106.
      
Association of Immune-Related Adverse Events and the Efficacy of Anti-PD-(L)1 Monotherapy in Non-Small Cell Lung Cancer: Adjusting for Immortal-Time Bias
Ying Yu, Ning Chen, Sizhe Yu, Wanji Shen, Wanchen Zhai, Hui Li, Yun Fan
Received October 11, 2023   Accepted December 30, 2023   Published online January 2, 2024
DOI: https://doi.org/10.4143/crt.2023.1118    
[Accepted]
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Journal Impact Factor 4.6
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI